Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Amy Simon

Chief Medical Officer at Beam Therapeutics Inc. (BEAM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $607K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 29SEC BEAMBeam Therapeutics Inc. Sell Plan 16,66785,696 held (−16%) $25.74 $429K -8.8%
Jul 2SEC BEAMBeam Therapeutics Inc. Sell Plan 373102,363 held (−0%) $34.73 $13K -32.4%
Apr 6SEC BEAMBeam Therapeutics Inc. Sell Plan 6,700102,735 held (−6%) $24.58 $165K -4.5%
  • Sell

    Chief Medical Officer Amy Simon sold $429K of BEAM at $25.74 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Amy Simon sold $13K of BEAM at $34.73 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Chief Medical Officer Amy Simon sold $165K of BEAM at $24.58 — pre-scheduled 10b5-1 plan sale.